• Home
  • 2022 Webinar Series - First National Bank of Omaha

View Recording
PowerPoint
Upcoming Grail Events: 11/7/24 & 12/11/24

2022 Webinar Series - First National Bank of Omaha

  • 06/15/2022
  • 12:00 PM - 1:00 PM
  • Zoom

Registration

Registration is closed


Buying a Home in 2022 - Position Yourself for Success

FNBO is a full-service mortgage lender, who can help to guide you through the mortgage process.  Positioning yourself for success starts by understanding the market and getting your mortgage from a knowledgeable mortgage lender, who has mortgage products geared towards your profession.  Whether you’re a homebuyer, building a home, or refinancing, we’ve got you covered! Our local and dedicated loan officers will guide you through the mortgage process and answer all of your questions. Our goal is simple: happy homeowners.

As a medical professional*, your financial needs are unique and require solutions that are tailored to your lifestyle.  Our Physician Mortgage Loan offers competitive rates and flexible terms. 

Join us for a presentation where we will have mortgage lenders on hand to cover the features of mortgage products tailored towards medical professions.  We will also have designated time set aside so that you can ask questions.


Recording
Mortgage Contact: Kristi Lyons • (402) 602-6746 • klyons@fnni.com
Wealth Management Contact: Steve Adams • (402) 602-8774 • stevenadams@fnni.com

Additional publication resources:
https://grail.com/manuscripts/

1. Validation for current Galleri assay: Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set (All of our sensitivity, specificity test performance metrics are from this study)

2. Implementation study: Blood-based tests for multi cancer early detection (PATHFINDER): a prospective cohort study (Our 43% positive predictive value comes from this study)

3. Case series publication (Three stage 1 diagnoses): A multi-cancer early detection blood test using machine learning detects early-stage cancers lacking USPSTF-recommended screening.

Powered by Wild Apricot Membership Software